Related Experiment Videos
Omeprazole and the gastric mucosa
Abstract:
The potential for either omeprazole or its sulphenamide to interact with DNA was investigated by incubating tritiated omeprazole at either neutral or acidic pH with either purified prokaryotic (Escherichia coli) or purified eukaryotic (salmon sperm) DNA. Each incubation was carried out for 30 min. The DNA was separated on agarose gels, stained with ethidium bromide, and the radioactivity in the DNA determined. No radioactivity was associated with the DNA on the gel with either prokaryotic or eukaryotic DNA or with either protocol. No interaction with the DNA was found, thus excluding the possibilities of base modification, DNA strand breakage or intercalation. It was concluded that neither omeprazole nor its gastric metabolites are genotoxic.
Insights
Omeprazole and its metabolites were tested for DNA interaction. Studies found no genotoxic effects, indicating safety for genetic material.
Area of Science:
- Pharmacology
- Molecular Biology
- Genotoxicology
Background:
- Proton pump inhibitors like omeprazole are widely used.
- Understanding potential drug-DNA interactions is crucial for safety assessment.
Purpose of the Study:
- To investigate the potential for omeprazole and its sulphenamide metabolite to interact with DNA.
- To determine if omeprazole or its metabolites exhibit genotoxic properties.
Main Methods:
- Incubation of tritiated omeprazole with prokaryotic (E. coli) and eukaryotic (salmon sperm) DNA at neutral and acidic pH.
- Separation of DNA using agarose gel electrophoresis.
- Quantification of radioactivity associated with DNA to detect interactions.
Main Results:
- No radioactivity was detected in association with either prokaryotic or eukaryotic DNA.
- Analysis excluded DNA base modification, strand breakage, or intercalation by omeprazole or its metabolites.
Conclusions:
- Omeprazole and its gastric metabolites do not interact with DNA.
- The findings conclude that omeprazole and its metabolites are not genotoxic.